Neil Sheth
Family Medicine · Chandler, AZNPI 1982802930
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (44.0%), travel and lodging and speaking fees — rather than concentrated in one kind of arrangement. 30 manufacturers reported payments, led by Amarin Pharma, Inc. at 51.1% of the total. Reporting peaked in 2020 at $4,934 and has fallen 94.9% since, to $250 in 2025. Among family medicine clinicians in AZ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 134 payments — averaging $96.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Amarin Pharma, Inc.$7K
- Genentech USA, Inc.$2K
- Amgen$944
- Esperion Therapeutics, Inc.$802
- Novartis$639
- Regeneron Healthcare Solutions, Inc.$408
- plus $2K from 24 others
Across 80,460 payments — averaging $82.76 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Modernatx, Inc.$5.5M
- Eli Lilly$806K
- Sanofi US Services Inc.$109K
- Ironwood Pharmaceuticals, Inc$81K
- Novo Nordisk AS$76K
- Vertex$76K
- plus $57K from 6 others
What the payments were for
- Speaking & faculty fees$3,18025%
- Travel & lodging$3,99231%
- Food & beverage$5,68844%
- Education$781%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Amarin Pharma, Inc. | 27 | $6,611 |
| Genentech USA, Inc. | 6 | $1,531 |
| Amgen | 15 | $944 |
| Esperion Therapeutics, Inc. | 11 | $802 |
| Novartis | 8 | $639 |
| Regeneron Healthcare Solutions, Inc. | 6 | $408 |
| Novo Nordisk | 11 | $360 |
| Bayer | 2 | $210 |
| Kowa Pharmaceuticals America, Inc. | 3 | $207 |
| Regeneron | 4 | $167 |
| Johnson & Johnson | 3 | $166 |
| Biohaven Pharmaceuticals, Inc. | 1 | $123 |
| AstraZeneca | 9 | $108 |
| Teva Pharmaceuticals USA, Inc. | 1 | $96 |
| Sanofi-aventis U.S. LLC | 2 | $96 |
| GSK | 1 | $70 |
| Sanofi | 1 | $68 |
| Lilly USA, LLC | 4 | $54 |
| Medtronic(2 entities) | 2 | $44 |
| Pfizer | 2 | $38 |
| Arbor Pharmaceuticals, Inc. | 3 | $38 |
| Abbott | 1 | $26 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $25 |
| Merck | 2 | $23 |
| Boston Scientific | 1 | $23 |
| Silk Road Medical, Inc. | 1 | $19 |
| Astellas Pharma US Inc | 1 | $16 |
| AbbVie | 1 | $13 |
| Medicure Pharma Inc. | 1 | $11 |
| Travere Therapeutics, Inc. | 2 | $2 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,939 in reported general payments places this provider in the 95th percentile of 2,099 family medicine providers in Arizona.
Other family medicine in Chandler
- Jessica BlancoChandler$447K
- Ronald SellChandler$17K
- Richard leChandler$17K
- Douglas CunninghamPhoenix$1.8M
- Mitchell EdelsteinPhoenix$741K
- Lorena Jauregui-CovarrubiasYuma$491K
- Sam FereidouniScottsdale$486K
- Heather ElwoodPhoenix$236K
- Ryan CaseyYuma$231K
- Suzanne BentzMesa$174K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.